Cardinal Health (FRA:CLH) EBIT: €2,014 Mil (TTM As of Mar. 2026)


FRA:CLH Cardinal Health Inc FRA:CLH
81 GF Score
Price €193.25
GF Value €119.66
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cardinal Health EBIT?

Cardinal Health FRA:CLH +0.16% 81 EBIT is €2,014 Mil as of Mar. 2026. GuruFocus rates FRA:CLH with a GF Score™ of 81/100 and a GF Value™ of €119.66 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Cardinal Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €426 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €2,014 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cardinal Health's annualized ROC % for the quarter that ended in Mar. 2026 was 16.93%. Cardinal Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 68.37%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cardinal Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.92%.

Cardinal Health  (FRA:CLH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cardinal Health's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=2913.32 * ( 1 - 3.06% )/( (16681.182 + 16691.04)/ 2 )
=2824.172408/16686.111
=16.93 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=49602.882 - 36409.436 - ( 2371.558 - max(0, 36990.156 - 33502.42+2371.558))
=16681.182

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=49035.985 - 35740.07 - ( 3405.505 - max(0, 36320.485 - 32925.36+3405.505))
=16691.04

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Cardinal Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1705.78/( ( (2456.958 + max(-5278.574, 0)) + (2532.72 + max(-6220.215, 0)) )/ 2 )
=1705.78/( ( 2456.958 + 2532.72 )/ 2 )
=1705.78/2494.839
=68.37 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11667.348 + 17179.064 + 2284.45) - (36409.436 + 0 + 0)
=-5278.574

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11805.52 + 15576.055 + 2138.28) - (35740.07 + 0 + 0)
=-6220.215

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cardinal Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2014.359/51414.715
=3.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health EBIT Related Terms

Cardinal Health EBIT Historical Data

* Premium members only.

The historical data trend for Cardinal Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardinal Health EBIT Chart

Cardinal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 417.49 -602.60 689.48 1,163.11 2,007.97

Cardinal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 683.58 397.09 577.66 613.17 426.45

FRA:CLH vs COR, HSIC, MCK: EBIT Comparison

For the Medical Distribution subindustry, Cardinal Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardinal Health EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cardinal Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cardinal Health's EV-to-EBIT falls into.


FRA:CLH
81GF Score
Cardinal Health Inc FRA:CLH
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cardinal Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2,014 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €2,014 Mil mean?
Cardinal Health (FRA:CLH) has a EBIT of €2,014 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cardinal Health.
Is Cardinal Health's EBIT too high?
Cardinal Health's current EBIT is €2,014 Mil. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's EBIT compare to COR and HSIC?
Cardinal Health's EBIT of €2,014 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cardinal Health. Cardinal Health's current EBIT is €2,014 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (FRA:CLH) is currently considered Significantly Overvalued. The stock's GF Value™ is €119.66, compared to a current price of €193.25 — trading 61.5% above its estimated fair value. The current EBIT is €2,014 Mil. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cardinal Health (FRA:CLH), the current EBIT is €2,014 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cardinal Health (FRA:CLH) Overvalued in 2026?

Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued. The current stock price of €193.25 is trading 61.5% above its estimated GF Value™ of €119.66. GuruFocus considers Cardinal Health to be Significantly Overvalued.

Key valuation signals for FRA:CLH:

  • EBIT: €2,014 Mil
  • GF Value™: €119.66 vs. price of €193.25 (61.5% above fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the FRA:CLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cardinal Health Business Description

Address 7000 Cardinal Place, Dublin, OH, USA, 43017
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score

Get the complete analysis for FRA:CLH

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€193.25
Price
€119.66
GF Value